Prica A - Search Results

1

IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia.

Assouline S, Amrein L, Aloyz R, Banerji V, Caplan S, Owen C, Hasegawa W, Robinson S, Shivakumar S, Prica A, Peters A, Hagerman L, Rodriguez L, Skamene T, Panasci L, Chen BE, Hay AE. Assouline S, et al. Among authors: prica a. Leuk Lymphoma. 2020 Jul;61(7):1653-1659. doi: 10.1080/10428194.2020.1734594. Epub 2020 Mar 10. Leuk Lymphoma. 2020. PMID: 32154751 Clinical Trial.

2

Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin's Lymphoma.

Ortega C, Eshet Y, Prica A, Anconina R, Johnson S, Constantini D, Keshavarzi S, Kulanthaivelu R, Metser U, Veit-Haibach P. Ortega C, et al. Among authors: prica a. Cancers (Basel). 2023 Mar 30;15(7):2056. doi: 10.3390/cancers15072056. Cancers (Basel). 2023. PMID: 37046717 Free PMC article.

3

Cyclophosphamide and Bortezomib With Prednisone or Dexamethasone for the Treatment of Relapsed and Refractory Multiple Myeloma.

Reece DE, Trieu Y, Masih-Khan E, Atenafu EG, Chen C, Prica A, Tiedemann R, Trudel S, Kukreti V. Reece DE, et al. Among authors: prica a. Clin Lymphoma Myeloma Leuk. 2016 Jul;16(7):387-94. doi: 10.1016/j.clml.2016.04.012. Epub 2016 May 10. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27349765

4

Emerging therapies for the treatment of relapsed or refractory follicular lymphoma.

MacDonald D, Prica A, Assouline S, Christofides A, Lawrence T, Sehn LH. MacDonald D, et al. Among authors: prica a. Curr Oncol. 2016 Dec;23(6):407-417. doi: 10.3747/co.23.3405. Epub 2016 Dec 21. Curr Oncol. 2016. PMID: 28050137 Free PMC article. Review.

5

Improving CD20 antibody therapy: obinutuzumab in lymphoproliferative disorders.

Prica A, Crump M. Prica A, et al. Leuk Lymphoma. 2019 Mar;60(3):573-582. doi: 10.1080/10428194.2018.1498490. Epub 2019 Jan 22. Leuk Lymphoma. 2019. PMID: 30668192 Review.

6

Outcomes of patients with relapsed low-grade lymphoma retreated with rituximab are similar to rituximab naïve patients.

Vijenthira A, Maganti M, Kukreti V, Kuruvilla J, Tiedemann R, Chen C, Crump M, Prica A. Vijenthira A, et al. Among authors: prica a. Leuk Lymphoma. 2019 Oct;60(10):2576-2579. doi: 10.1080/10428194.2019.1585837. Epub 2019 Apr 18. Leuk Lymphoma. 2019. PMID: 30997853 No abstract available.

7

Emerging therapies for the treatment of relapsed or refractory diffuse large B cell lymphoma.

Skrabek P, Assouline S, Christofides A, MacDonald D, Prica A, Sangha R, Matthews BA, Sehn LH. Skrabek P, et al. Among authors: prica a. Curr Oncol. 2019 Aug;26(4):253-265. doi: 10.3747/co.26.5421. Epub 2019 Aug 1. Curr Oncol. 2019. PMID: 31548805 Free PMC article. Review.

8

Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma-type post-transplant lymphoproliferative disorder.

Jain MD, Lam R, Liu Z, Stubbins RJ, Kahlon A, Kansara R, Goswami R, Humar A, Prica A, Sehn LH, Slack GW, Crump M, Savage KJ, Peters AC, Kuruvilla J. Jain MD, et al. Among authors: prica a. Br J Haematol. 2020 Apr;189(1):97-105. doi: 10.1111/bjh.16304. Epub 2020 Feb 18. Br J Haematol. 2020. PMID: 32068243 Free article.

9

An open-label, pharmacokinetic study of lenalidomide and dexamethasone therapy in previously untreated multiple myeloma (MM) patients with various degrees of renal impairment - validation of official dosing guidelines.

Chen CI, Cao Y, Trudel S, Reece DE, Kukreti V, Tiedemann R, Prica A, Paul H, Le LW, Levina O, Kakar S, Lau A, Chen H, Chen E. Chen CI, et al. Among authors: prica a. Leuk Lymphoma. 2020 Aug;61(8):1860-1868. doi: 10.1080/10428194.2020.1747064. Epub 2020 May 31. Leuk Lymphoma. 2020. PMID: 32476520

10

Efficacy and safety of stem cell mobilization following gemcitabine, dexamethasone, cisplatin (GDP) salvage chemotherapy in patients with relapsed or refractory lymphoma.

Tang C, Espin-Garcia O, Prica A, Kurkreti V, Kridel R, Keating A, Patriquin CJ, Kuruvilla J, Crump M. Tang C, et al. Among authors: prica a. Leuk Lymphoma. 2020 Sep;61(9):2153-2160. doi: 10.1080/10428194.2020.1762882. Epub 2020 Jun 1. Leuk Lymphoma. 2020. PMID: 32482114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters